FDx Advisors’s Natus Medical Inc NTUS Stock Holding History

FDx Advisors’s Portfolio NTUS Stock Details NTUS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-5,766	Closed	-$220K	–	1286
2017 Q4	$220K	Sell	5,766 -20	-0.3%	-$798	0.01%	1166
2017 Q3	$217K	Sell	5,786 -1,278	-18%	-$45.1K	0.01%	1184
2017 Q2	$263K	Buy	7,064 +27	+0.4%	+$975	0.01%	1033
2017 Q1	$276K	Sell	7,037 -1,853	-21%	-$69.5K	0.01%	1003
2016 Q4	$309K	Buy	+8,890	New	+$349K	0.01%	938

Other funds holding NTUS

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

SAM

Silvercrest Asset Management New York $13.8B AUM 28.39% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

CIM

Confluence Investment Management St. Louis, Missouri $6.4B AUM 9.79% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

IAM

Impax Asset Management Portsmouth, New Hampshire $1.69B AUM 16.26% 1-Year Est. Return

VCM

Voce Capital Management San Francisco, California $57.8M AUM 9.28% 1-Year Est. Return

FDx Advisors's NTUS Position: Q1 2018 in Review

FDx Advisors sold out of Natus Medical Inc (NTUS) in Q1 2018, closing a stake of 5,766 shares — an estimated $220K sold.

FDx Advisors first reported a position in NTUS in Q4 2016 and held it in 5 quarters. The position peaked at $309K in Q4 2016. 184 funds tracked by Wall St. Rank hold NTUS as of Q1 2018.

FDx Advisors reported no remaining Natus Medical Inc position as of Q1 2018 after selling out during the quarter.
FDx Advisors sold 5,766 Natus Medical Inc shares in Q1 2018, an estimated $220K.
FDx Advisors first reported a position in Natus Medical Inc in Q4 2016 and held it in 5 quarters.
FDx Advisors's Natus Medical Inc position peaked at $309K in Q4 2016.
184 funds tracked by Wall St. Rank held Natus Medical Inc as of Q1 2018.

Based on FDx Advisors's 13F filing for Q1 2018, filed 2 May 2018.